NCT03380052

OLGA and OLGIM Stage System for Gastric Cancer

The Evaluation of OLGA and OLGIM Stage Systems for Prediction of Gastric Cancer Risk and Interaction With Other Risk Factors According to Lauren's Classification

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,900 (actual)
• Sponsor: Seoul National University Bundang Hospital · Academic / Other
• Sex: All
• Age: 25 Years – 80 Years
• Healthy volunteers: Accepted

Summary

To validate OLGA and OLGIM staging system with serum pepsinogen for estimating GC risk according to Lauren's histologic classification in South Korea. Also attempted to estimate synergistic interaction among the several risk factors to help establish surveillance strategy.

Detailed description

To validated the OLGA and OLGIM staging system with serum pepsinogen to estimate gastric cancer risk according to Lauren's histologic classification in South Korea, where the incidence rate of GC is high. In addition, the investigators attempted to investigate the interaction among the several risk factors including OLGA or OLGIM staging system for the risk of GC to help establish surveillance strategy.

Conditions

• Stomach Neoplasms
• Atrophic Gastritis
• Intestinal Metaplasia

Timeline

• Start date: 2006-02-01
• Primary completion: 2021-01-01
• Completion: 2022-01-01
• First posted: 2017-12-20
• Last updated: 2023-04-13

Locations

1 site across 1 country: South Korea